This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity | MicrobiomeTrials
← Back to trials NCT00092222
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2004-10-28Est. Completion: 2026-10-01
Enrollment target: 75 participantsLocations National Institutes of Health Clinical Center, Bethesda, Maryland, United States Other microbiome trials you might be interested in B-cell Acute Lymphoblastic Leukemia Diffuse Large B-cell Lymphoma Burkitt Lymphoma Neuroblastoma Ewing Sarcoma
Substudy 01A is part of a platform study. The purpose of this study is to assess the efficacy and safety of zilovertamab…
Los Angeles, United States Est. completion Mar 31, 2029
Recurrent Burkitt Lymphoma Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements Refractory Burkitt Lymphoma Refractory High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
This phase II/III trial tests adding glofitamab to standard of care chemoimmunotherapy in patients with Burkitt and high…
Multiple Locations Est. completion Nov 1, 2033
Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes (MDS) Myeloproliferative Neoplasm
Cancer and treatment-related cognitive changes, such as thinking or remembering, hinder resumption of normal routine and…
Omaha, United States Est. completion Jul 2027